EA201291235A1 - Новые способы - Google Patents

Новые способы

Info

Publication number
EA201291235A1
EA201291235A1 EA201291235A EA201291235A EA201291235A1 EA 201291235 A1 EA201291235 A1 EA 201291235A1 EA 201291235 A EA201291235 A EA 201291235A EA 201291235 A EA201291235 A EA 201291235A EA 201291235 A1 EA201291235 A1 EA 201291235A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new ways
formula
atherosclerosis
cardiovascular
intermediates
Prior art date
Application number
EA201291235A
Other languages
English (en)
Other versions
EA026569B1 (ru
Inventor
Кевин Стюарт Кардуэлл
Клэр Франсес Кроуфорд
Сьюзан Хелен Дэйвис
Чарльз Эдвард Уэйд
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44992024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201291235(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA201291235A1 publication Critical patent/EA201291235A1/ru
Publication of EA026569B1 publication Critical patent/EA026569B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Изобретение относится к способам получения соединения формулы (I) и его промежуточным соединениям. Соединения формулы (I) полезны при лечении сердечно-сосудистых и воспалительных заболеваний, таких как атеросклероз.
EA201291235A 2010-05-17 2011-05-17 Способы получения определенных пиримидиновых соединений и их промежуточные соединения EA026569B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34522410P 2010-05-17 2010-05-17
PCT/US2011/036821 WO2011146494A1 (en) 2010-05-17 2011-05-17 Novel processes

Publications (2)

Publication Number Publication Date
EA201291235A1 true EA201291235A1 (ru) 2013-04-30
EA026569B1 EA026569B1 (ru) 2017-04-28

Family

ID=44992024

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291235A EA026569B1 (ru) 2010-05-17 2011-05-17 Способы получения определенных пиримидиновых соединений и их промежуточные соединения

Country Status (24)

Country Link
US (2) US9447052B2 (ru)
EP (1) EP2571857B1 (ru)
JP (1) JP6027529B2 (ru)
KR (1) KR20130089157A (ru)
CN (2) CN105837520A (ru)
AR (1) AR081399A1 (ru)
AU (1) AU2011256270B2 (ru)
BR (1) BR112012030532A2 (ru)
CA (1) CA2799520C (ru)
CL (1) CL2012003206A1 (ru)
CO (1) CO6630197A2 (ru)
CR (1) CR20120630A (ru)
DO (1) DOP2012000289A (ru)
EA (1) EA026569B1 (ru)
IL (1) IL223068A0 (ru)
MA (1) MA34301B1 (ru)
MX (1) MX2012013387A (ru)
NZ (1) NZ603672A (ru)
PE (1) PE20130318A1 (ru)
SG (1) SG185559A1 (ru)
TW (1) TW201209043A (ru)
UY (1) UY33388A (ru)
WO (1) WO2011146494A1 (ru)
ZA (1) ZA201208631B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201209043A (en) * 2010-05-17 2012-03-01 Glaxo Group Ltd Novel processes
WO2015087239A1 (en) 2013-12-11 2015-06-18 Ranbaxy Laboratories Limited Processes for the preparation of darapladib and its intermediates
WO2015092687A2 (en) 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Process for the purification of darapladib
US11583596B2 (en) 2017-09-26 2023-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Radiolabeled Darapladib and analogs thereof and their use as imaging compounds
US10866963B2 (en) * 2017-12-28 2020-12-15 Dropbox, Inc. File system authentication

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143516B (de) * 1961-04-27 1963-02-14 Bayer Ag Verfahren zur Herstellung von Peptiden
US4277465A (en) 1978-08-26 1981-07-07 Kyoto Yakuhin Kogyo Kabushiki Kaisha Adjuvant for promoting absorption of therapeutically active substances through the digestive tract
US4235776A (en) * 1979-03-15 1980-11-25 Eli Lilly And Company Tetrahydro-2H-benzo[c]pyrroles
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4619941A (en) * 1984-11-19 1986-10-28 American Cyanamid Company N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents
WO1999024420A1 (en) 1997-11-06 1999-05-20 Smithkline Beecham Plc Pyrimidinone compounds and pharmaceutical compositions containing them
US6750228B1 (en) * 1997-11-14 2004-06-15 Pharmacia Corporation Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US6503745B1 (en) 1998-11-05 2003-01-07 Biocryst Pharmaceuticals, Inc. Cyclopentane and cyclopentene compounds and use for detecting influenza virus
AU766003B2 (en) * 1999-05-01 2003-10-09 Smithkline Beecham Plc Pyrimidinone compounds
BRPI0108396B1 (pt) * 2000-02-16 2015-05-19 Smithkline Beecham Plc Derivados de pirimidina-4-ona como inibidores de ldl-pla2
GB0119795D0 (en) * 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process
TW201209043A (en) * 2010-05-17 2012-03-01 Glaxo Group Ltd Novel processes

Also Published As

Publication number Publication date
ZA201208631B (en) 2013-09-25
CA2799520C (en) 2016-09-13
KR20130089157A (ko) 2013-08-09
AR081399A1 (es) 2012-08-29
US9725420B2 (en) 2017-08-08
US20160347720A1 (en) 2016-12-01
TW201209043A (en) 2012-03-01
AU2011256270A1 (en) 2012-12-20
JP6027529B2 (ja) 2016-11-16
EP2571857A4 (en) 2013-11-20
CL2012003206A1 (es) 2013-01-25
EP2571857B1 (en) 2017-08-23
CA2799520A1 (en) 2011-11-24
CN103003249A (zh) 2013-03-27
JP2013530948A (ja) 2013-08-01
CN105837520A (zh) 2016-08-10
NZ603672A (en) 2015-01-30
IL223068A0 (en) 2013-02-03
DOP2012000289A (es) 2013-04-15
US9447052B2 (en) 2016-09-20
UY33388A (es) 2011-12-01
CR20120630A (es) 2013-02-15
WO2011146494A1 (en) 2011-11-24
AU2011256270B2 (en) 2015-11-26
EA026569B1 (ru) 2017-04-28
US20130060028A1 (en) 2013-03-07
MA34301B1 (fr) 2013-06-01
CN103003249B (zh) 2016-04-27
PE20130318A1 (es) 2013-04-11
BR112012030532A2 (pt) 2015-09-29
MX2012013387A (es) 2012-12-10
EP2571857A1 (en) 2013-03-27
CO6630197A2 (es) 2013-03-01
SG185559A1 (en) 2012-12-28

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
UA110338C2 (en) Chemical compounds
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
MX343561B (es) Compuestos de imidazolpiridazina.
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
UA114087C2 (xx) Похідні піридину
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
PH12015501494A1 (en) Method for producing substituted 5-fluoro-1h-pyrazolopyrimidines
EA201270254A1 (ru) Производные 5-фторпиримидинона
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UA111827C2 (uk) Спосіб отримання інгенол-3-ангелату
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
EA200900945A1 (ru) Новый способ синтеза агомелатина
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
EA201490846A1 (ru) Новые производные арилхинолина
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
EA200900946A1 (ru) Новый способ синтеза агомелатина
EA201391554A1 (ru) Способы получения макроциклических депсипептидов и новых промежуточных соединений
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
MX349548B (es) Compuestos de tienopirimidina.
IN2014KN01062A (ru)

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU